ProQR Therapeutics N.V. (PRQR)
NASDAQ: PRQR · IEX Real-Time Price · USD
1.860
-0.040 (-2.11%)
At close: Apr 18, 2024, 4:00 PM
1.900
+0.040 (2.15%)
After-hours: Apr 18, 2024, 4:02 PM EDT
ProQR Therapeutics Market Cap
ProQR Therapeutics has a market cap or net worth of $150.32 million as of April 18, 2024. Its market cap has decreased by -15.46% in one year.
Market Cap
150.32M
Enterprise Value
51.11M
1-Year Change
-15.46%
Ranking
Category
Stock Price
$1.86
Market Cap Chart
Since September 18, 2014, ProQR Therapeutics's market cap has decreased from $308.80M to $150.32M, a decrease of -51.32%. That is a compound annual growth rate of -7.23%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 17, 2024 | 154.60M | -4.98% |
Apr 16, 2024 | 162.70M | -2.22% |
Apr 15, 2024 | 166.40M | -7.04% |
Apr 12, 2024 | 179.00M | -4.33% |
Apr 11, 2024 | 187.10M | 1.74% |
Apr 10, 2024 | 183.90M | -5.40% |
Apr 9, 2024 | 194.40M | 12.18% |
Apr 8, 2024 | 173.30M | -3.62% |
Apr 5, 2024 | 179.80M | 1.35% |
Apr 4, 2024 | 177.40M | 2.60% |
Apr 3, 2024 | 172.90M | 1.23% |
Apr 2, 2024 | 170.80M | -4.15% |
Apr 1, 2024 | 178.20M | -4.35% |
Mar 28, 2024 | 186.30M | -3.77% |
Mar 27, 2024 | 193.60M | -0.87% |
Mar 26, 2024 | 195.30M | 0.46% |
Mar 25, 2024 | 194.40M | 0.41% |
Mar 22, 2024 | 193.60M | -0.87% |
Mar 21, 2024 | 195.30M | -2.79% |
Mar 20, 2024 | 200.90M | -1.62% |
Mar 19, 2024 | 204.20M | 1.64% |
Mar 18, 2024 | 200.90M | -3.55% |
Mar 15, 2024 | 208.30M | 10.39% |
Mar 14, 2024 | 188.70M | -0.47% |
Mar 13, 2024 | 189.60M | 9.79% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
MediWound | 164.97M |
scPharmaceuticals | 164.77M |
Candel Therapeutics | 163.32M |
Augmedix | 163.03M |
P3 Health Partners | 158.90M |
Inogen | 158.39M |
INmune Bio | 158.27M |
Regulus Therapeutics | 157.77M |